Intrauterine devices (IUDs) primarily alleviate symptoms associated with uterine fibroids rather than directly reducing their size or eliminating them. Specifically, the levonorgestrel-releasing IUD is employed. This device functions by steadily releasing a progestin hormone into the uterus. This localized hormone delivery acts primarily on the uterine lining.
The primary benefit of hormonal IUDs in the context of fibroids is the reduction of heavy menstrual bleeding. Fibroids can distort the uterine cavity, leading to prolonged and excessive bleeding during menstruation, which can result in anemia and a diminished quality of life. By thinning the uterine lining, the IUD decreases the amount of blood lost during periods, effectively managing this common symptom. While IUDs offer a less invasive approach compared to surgery, they do not address the underlying fibroids themselves. Their efficacy centers on symptom management.
